Business Context and Reporting Period
This Form 8-K Current Report was filed by DaVita Inc. on February 26, 2010, with the earliest event reported dated March 5, 2010. The filing discloses the appointment of a new Chief Financial Officer (CFO) and the departure of the incumbent CFO.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and personnel changes.
Material Changes
- Executive Transition: Luis Borgen was named Chief Financial Officer, effective March 29, 2010, subject to Board approval.
- Departure: The incumbent CFO, Mr. Whitney, will step down effective March 29, 2010, but will remain in an executive role to assist with the transition.
- Compensation Package:
- Annual Base Salary: $450,000.
- Signing Bonus: $250,000.
- Discretionary Performance Bonus: Up to $225,000.
- Equity Grant: 60,000 stock-settled stock appreciation rights (vesting over 5 years) and 15,000 restricted stock units (vesting over 5 years).
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business performance. The primary risk disclosed relates to the transition of the CFO role and the specific terms of the new employment agreement, including termination provisions and non-solicitation clauses regarding employees, patients, and customers.
Investor Verification Checklist
- Confirm the Board of Directors' formal approval of Luis Borgen's appointment as CFO.
- Verify the exact closing price of DaVita common stock on the effective date to determine the base grant price for the stock appreciation rights.
- Review the specific definitions of "material cause" and "good reason" within the Employment Agreement to understand severance triggers.
- Monitor the transition period to ensure continuity in financial reporting and investor relations following Mr. Whitney's departure.